icer white paper affordable access to glp-1 obesity medications 2025 Our 2023 UPI Final Report is now published. Use the link in our bio navigate to our website to read. Swipe to learn more about our findings! #heor #icer #icerview #health Lifetime Social Returns From Expanding

One of the most consistent shifts reported by GLP-1 users is altered taste perception, particularly a heightened sensitivity to sweetness and a loss of appeal for previously enjoyable foods, especially those high in sugar. Food makers can reinvigorate taste buds for GLP-1 users There are tips and tricks food makers can harness to help make food more enjoyable for GLP-1 drug users

Patients with coexisting type 2 diabetes and hypertension, or obesity with elevated blood pressure, may derive particular benefit from these additional cardiovascular effects

While GIP doesnt slow gastric emptying like GLP-1 does, it still affects gut function

US Pharm US Pharm ABSTRACT: Patients at a high risk of developing type 2 diabetes mellitus are considered prediabetic